DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 913 filers reported holding DANAHER CORPORATION in Q2 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $13,000 | +8.3% | 135 | +0.7% | 0.12% | +9.2% |
Q4 2015 | $12,000 | -58.6% | 134 | -60.6% | 0.11% | -59.0% |
Q3 2015 | $29,000 | -99.9% | 340 | -99.9% | 0.27% | -8.0% |
Q2 2015 | $21,346,000 | +14.0% | 249,401 | +13.1% | 0.29% | +2.5% |
Q1 2015 | $18,727,000 | -5.9% | 220,582 | -5.0% | 0.28% | -1.1% |
Q4 2014 | $19,897,000 | +22.8% | 232,147 | +8.9% | 0.28% | +8.8% |
Q3 2014 | $16,201,000 | -2.2% | 213,230 | +1.4% | 0.26% | -1.5% |
Q2 2014 | $16,557,000 | +12.0% | 210,307 | +6.7% | 0.27% | +0.8% |
Q1 2014 | $14,784,000 | -9.5% | 197,124 | -6.8% | 0.26% | -4.0% |
Q4 2013 | $16,331,000 | +15.0% | 211,544 | +3.3% | 0.28% | +1.5% |
Q3 2013 | $14,198,000 | +13.1% | 204,812 | +3.2% | 0.27% | +8.4% |
Q2 2013 | $12,559,000 | – | 198,403 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
Third Point | 2,700,000 | $697,383,000 | 12.60% |
Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |